In this context, there is evidence for an increased frequency of circulating CD19+/ CD38hi/ CD24hi/IL-10+ B cells in active IBD patients as compared with inactive disease or healthy controls [29], suggesting that Breg cells may act downregulating gut inflammation in patients with disease activity [29]. Here, CD19 is linked to inflammatory bowel disease.